Loading...
Printed on 7/20/2026
For informational purposes only. This is not medical advice.
The Short Physical Performance Battery (SPPB) is a validated objective measure of lower-extremity function in older adults. It combines three domains, each scored 0 to 4: standing balance, usual gait speed, and repeated chair stands. The total score ranges 0 to 12, with lower scores associated with higher risk of disability, falls, hospitalization, nursing-home admission, and mortality.
Formula: SPPB total = balance (0-4) + gait speed (0-4) + chair stand (0-4), range 0-12.
Save your results with a free account
Keep a history of calculations, favorite tools, and access your dashboard anytime.
The SPPB consists of three lower-extremity function tests performed in a specific standardized sequence. Test 1 — Standing Balance Test (three positions): Present three standing balance positions in ascending difficulty; each position is timed for 10 seconds. Position 1 (Side-by-Side Stand): Ask the patient to stand with feet together side by side, arms folded across the chest. Demonstrate. Hold for 10 seconds. Position 2 (Semi-tandem Stand): Ask the patient to place the heel of one foot beside the toe of the other foot in a semi-tandem position. Hold for 10 seconds. Position 3 (Full Tandem Stand): Ask the patient to place the heel of one foot directly in front of the other foot in a full tandem position. Hold for 10 seconds (only attempted if semi-tandem is successfully held for 10 seconds). Balance scoring: 0 = cannot hold side-by-side for 10 seconds; 1 = holds side-by-side for 10 seconds but not semi-tandem; 2 = holds semi-tandem but not tandem, OR holds tandem for 3–9.99 seconds; 3 = holds tandem for 10 seconds. Test 2 — Gait Speed (4-metre walk): Using a stopwatch and a 4-metre course (marked with tape), ask the patient to walk at their usual pace from one mark to the other — time from the moment the patient's first foot crosses the starting line to when either foot crosses the 4-metre line. Two trials are performed; use the faster time. Gait speed score: 0 = cannot complete; 1 = >6.52 seconds; 2 = 4.66–6.52 seconds; 3 = 3.62–4.65 seconds; 4 = <3.62 seconds. Gait speed scoring cut-points correspond to walking speeds <0.61 m/s, 0.61–0.86 m/s, 0.87–1.10 m/s, and >1.10 m/s respectively.
Test 3 — Repeated Chair Stand Test: Use a straight-backed chair without armrests (seat height approximately 43 cm). Pre-test: ask the patient to cross arms across chest and stand from the chair once without using arms — this verifies they can perform the task. If unable: score 0. If able: perform 5 repeated chair stands, timed from 'Go' (patient starts seated) until they complete their 5th stand to a fully erect position (back straight, legs straight). Use a stopwatch, start on 'Go'. Chair stand score: 0 = unable to complete 5 stands; 1 = ≥16.70 seconds; 2 = 13.70–16.69 seconds; 3 = 11.20–13.69 seconds; 4 = ≤11.19 seconds. The five-times sit-to-stand test component assesses quad strength, power, and dynamic balance. Sum the three subtest scores: SPPB Total = Balance (0–4) + Gait Speed (0–4) + Chair Stand (0–4). Range: 0–12. A score of 0 = cannot attempt any test; 12 = excellent performance on all three. Document each subtest score separately — the subscore profile is as clinically important as the total.
SPPB interpretation thresholds: 10–12 = Good to excellent lower-extremity function — low near-term disability risk. Maintain with regular physical activity. Annual reassessment. Consider as baseline for monitoring. 8–9 = Fair/borderline function — some lower-extremity impairment but still moderate functioning. Evaluate which subtest is most impaired and target intervention. Balance deficit → balance training (Tai Chi, Otago program). Gait speed deficit → aerobic conditioning + gait training. Chair stand deficit → quadriceps strengthening. 4–7 = Moderate impairment — substantially elevated disability, fall, and hospitalization risk. Physical therapy referral for structured strength and balance program. Supplement SPPB with [TUG](/tools/get-up-and-go), [SARC-F](/tools/sarc-f), and [MNA-SF](/tools/mna-sf) for complete frailty/sarcopenia/nutrition assessment. 0–3 = Poor function — severely limited lower-extremity performance. High risk of disability, nursing home admission, and death. Comprehensive geriatric assessment (CGA) indicated. Physical therapy (even home-based) can produce meaningful gains. Advance care planning discussion may be appropriate. The Minimal Significant Change (MSC) for SPPB is approximately 0.5 points (group level) to 1 point (individual clinical significance). A change of 1 point or more between assessments represents a clinically meaningful change in lower-extremity function. In clinical trials, an SPPB change of ≥0.5 is considered meaningful for comparing intervention groups.
Geriatricians, geriatric medicine fellows, geriatric assessment nurses
SPPB is considered the gold-standard objective physical performance measure in geriatric medicine research and clinical practice. It was developed by Guralnik et al. at the National Institute on Aging (EPESE study — Established Populations for Epidemiologic Studies of the Elderly) and subsequently validated in multiple cohort studies showing SPPB predicts disability, nursing home admission, hospitalization, and mortality. In comprehensive geriatric assessment (CGA), SPPB provides the objective lower-extremity function component alongside self-reported functional measures (Katz ADL, Lawton IADL). SPPB subscore profiles (balance vs. gait vs. chair stand) direct specific intervention: impaired balance → balance training; impaired gait speed → aerobic conditioning; impaired chair stand → resistance training.
Cardiologists, heart failure nurses, cardiac rehabilitation specialists
Heart failure is associated with significant skeletal muscle wasting (cardiac cachexia) and exercise intolerance that impair physical function independent of cardiac function. SPPB quantifies lower-extremity physical performance in heart failure patients beyond the ejection fraction and NYHA class: SPPB ≤8 in heart failure patients predicts higher 1-year mortality, hospitalization, and functional decline independent of cardiac parameters. Serial SPPB measurement in cardiac rehabilitation programs documents functional improvement from exercise training — a clinically meaningful outcome beyond peak VO2. SPPB is increasingly included in heart failure clinical trial outcome batteries as a patient-centered physical function endpoint.
Geriatricians, rehabilitation specialists, sports medicine physicians, dietitians
SPPB ≤8 is one of the three recommended physical performance criteria for 'severe sarcopenia' in the EWGSOP2 (European Working Group on Sarcopenia in Older People 2019) diagnostic algorithm. In the EWGSOP2 pathway: SARC-F ≥4 triggers handgrip strength assessment (probable sarcopenia); if grip strength is low, DXA or BIA assesses muscle mass (confirmed sarcopenia); if SPPB ≤8 is additionally present = severe sarcopenia. SPPB provides a comprehensive physical performance battery that captures multiple motor components relevant to sarcopenia: balance testing (postural stability), gait speed (global lower-extremity function predictor), and chair stand time (quadriceps strength and power). SPPB combined with grip strength and muscle mass assessment provides the complete EWGSOP2 sarcopenia characterization.
Surgeons, anesthesiologists, perioperative physiotherapists, prehabilitation coordinators
Pre-operative SPPB establishes an objective physical function baseline for major elective surgery and quantifies prehabilitation response. Pre-operative SPPB ≤8 independently predicts post-operative complications, extended hospital stay, and non-home discharge in major colorectal, urological, and orthopedic surgeries. Prehabilitation programs (4–8 weeks structured exercise before elective surgery) use serial SPPB to document physical function improvement before surgery and select patients who have achieved adequate function for safe proceeding. Post-operative SPPB at 3 and 6 months quantifies functional recovery trajectory relative to pre-operative baseline — a meaningful patient-centered outcome for surgical program quality evaluation.
Geriatric oncologists, oncology physical therapists, cancer survivorship coordinators
Sarcopenia and physical function impairment are prevalent in older adults with cancer and are independent predictors of chemotherapy toxicity, treatment-related functional decline, and survival. SPPB provides a comprehensive physical performance battery for geriatric oncology assessment: SPPB ≤8 before chemotherapy predicts severe toxicity, dose reductions, and early treatment discontinuation independent of performance status (ECOG/KPS). During cancer treatment, serial SPPB tracks treatment-related functional decline — triggering exercise and nutritional intervention before irreversible sarcopenia develops. In cancer survivorship programs, SPPB documents long-term physical function recovery and identifies persistent impairment requiring ongoing rehabilitation.
SPPB validity depends on precise timing with a stopwatch, accurate 4-metre course measurement, and strict application of the published scoring cutoff times. The gait speed subscale cutoffs (3.62, 4.65, 6.52 seconds for the 4-metre course) and chair stand cutoffs (11.19, 13.69, 16.69 seconds for 5 stands) are precise — do not round to the nearest bracket. Record the raw time and apply the table: 4.70 seconds on gait speed = score 2, not score 3 (which would require <4.65 seconds). Consistent use of exact cutoffs is essential when comparing scores over time or benchmarking against published norms.
A total SPPB of 7 can result from multiple different subscores profiles: Balance=3, Gait=2, Chair=2; or Balance=1, Gait=3, Chair=3; or Balance=2, Gait=2, Chair=3. Each profile points to a different primary deficit and intervention priority: Isolated balance deficit → balance-specific training (tandem stance, Tai Chi, Otago program); Isolated gait speed deficit → aerobic conditioning, gait training, possible cardiovascular assessment; Isolated chair stand deficit → quadriceps strength training, check for knee OA or pain limiting effort. Always document and review all three subscores, not just the total.
The SPPB gait speed test specifies two timed trials, with the faster time used for scoring. This accounts for trial-to-trial variability and ensures the score reflects the patient's best comfortable gait speed rather than a single performance that may be affected by distraction or gait initiation delay. Some patients walk faster on the second trial when they understand the task better. Before starting, ensure the patient understands the instructions: 'Walk at your usual comfortable pace, as if you were walking down the street.' Do not instruct them to walk as fast as possible — the test measures usual comfortable gait speed, not maximum speed.
The most powerful single predictor from the SPPB battery is gait speed itself: walking speed <0.8 m/s (equivalent to gait speed score 0 or 1 on the 4-metre test) is associated in population studies with dramatically elevated risk of mortality, disability, hospitalization, and nursing home admission, independent of age, sex, BMI, and chronic conditions (Studenski et al., JAMA 2011). Gait speed <0.6 m/s (gait score 0) carries particularly high risk. A patient who scores well on balance and chair stands but has SPPB gait score of 0 or 1 should be investigated for cardiovascular, pulmonary, or musculoskeletal causes of slow gait, and should be enrolled in a physical activity program targeting gait speed improvement.
When monitoring functional trajectory over time with serial SPPB, a change of 1 point or more in the total score represents a clinically meaningful change in lower-extremity function. A decline of 1 point (e.g., from SPPB 8 to SPPB 7) between assessments warrants clinical investigation: new musculoskeletal pathology, cardiorespiratory decompensation, medication change causing sedation or orthostasis, sarcopenia progression, or nutritional decline. An improvement of 1 point following exercise intervention documents treatment benefit. Document total and subscores at each assessment with date to enable trend analysis.
Inability to complete 5 chair stands without arms (chair stand score 0) reflects severe quadriceps weakness that predicts falls, fractures, and inability to manage stairs, transfers, and toileting independently. If a patient scores 0 on chair stands: verify the chair height and technique (arms crossed, seat height ~43 cm); rule out acute pain or injury preventing effort; evaluate for sarcopenia (SARC-F + grip strength); and refer to physiotherapy for targeted lower extremity strengthening. A patient who can stand from the chair once (to verify they can perform the test) but cannot complete 5 stands is typically limited by muscular endurance (sarcopenia) or pain rather than neurological impairment — these are typically addressable with resistance training.
Physical frailty (SPPB ≤8) combined with mild cognitive impairment is increasingly recognized as 'cognitive frailty' — a high-risk condition with worse outcomes than either alone. SPPB does not assess cognition, but combining SPPB with Mini-Cog or MoCA in the same assessment provides both physical and cognitive function profiles. In patients with both SPPB ≤8 and positive Mini-Cog screen: comprehensive geriatric assessment with both physical and cognitive components is essential; exercise programs need to consider cognitive impairment in program delivery (simplified instructions, caregiver involvement); medication review for both frailty-contributing and cognition-impairing drugs is a priority.
SPPB developed by Guralnik JM, Simonsick EM, Ferrucci L et al. (J Gerontol 1994) from the EPESE (Established Populations for Epidemiologic Studies of the Elderly) study, n=5,000+ community-dwelling elderly. Predictive validity for mortality and disability: Guralnik JM et al. (NEJM 1995). Gait speed as global health predictor: Studenski S et al. (JAMA 2011) — meta-analysis 34,485 participants, gait speed predicts survival independent of age, sex, and health conditions. Minimum clinically important difference: Perera S et al. (J Gerontol 2006) — MCID 0.5 points (group level). EWGSOP2 sarcopenia severity criterion: Cruz-Jentoft AJ et al. (Age Ageing 2019). LIFE physical activity trial primary outcome: Pahor M et al. (JAMA 2014).
Lower SPPB scores indicate poorer physical performance and higher adverse-outcome risk; higher scores indicate stronger functional reserve.
Use in geriatric clinics, rehabilitation, prehabilitation, and chronic-disease follow-up where objective mobility/strength performance stratification is needed.
Requires standardized test administration and may be affected by acute pain, neurologic deficits, and temporary illness, so context is important.
For related assessments, see Timed Up and Go, FRAIL Scale and Clinical Frailty Scale.
Disclaimer: This tool is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about your health.
April 21, 2026 · trust-baseline
Clinical trust metadata enabled for this tool page with structured review/version fields.
Assess mobility and fall risk with the Timed Up and Go (TUG) test. TUG >12 seconds indicates high fall risk. Times the performance of standing, walking 3 meters, turning, and returning to seated.
OpenGeriatricsScreen frailty using the 5-item FRAIL scale (Fatigue, Resistance, Ambulation, Illnesses, Loss of weight).
OpenGeriatricsAssess frailty using the Rockwood Clinical Frailty Scale (CFS 1–9): Very Fit to Terminally Ill. Used for hospice eligibility, prognostication, ICU triage, surgical risk stratification, and goals-of-care discussions.
OpenGeriatricsScreen for probable sarcopenia risk using SARC-F (0-10) across strength, walking, chair rise, stair climbing, and falls.
Open